Number of employees
6306
Annual revenue
$1981220000
bioTheranostics, part of the worldwide bioMérieux group, develops molecular diagnostic tests that include supporting the selection of individualized oncology therapies through improved cancer classification and better breast cancer prognosis and recurrence risk stratification. The company operates a CLIA-certified, CAP-accredited diagnostic service laboratory in San Diego, CA.